These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
448 related items for PubMed ID: 17904589
1. The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition. Scherma M, Medalie J, Fratta W, Vadivel SK, Makriyannis A, Piomelli D, Mikics E, Haller J, Yasar S, Tanda G, Goldberg SR. Neuropharmacology; 2008 Jan; 54(1):129-40. PubMed ID: 17904589 [Abstract] [Full Text] [Related]
2. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats. Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR. J Pharmacol Exp Ther; 2008 Nov; 327(2):482-90. PubMed ID: 18725543 [Abstract] [Full Text] [Related]
3. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. Solinas M, Tanda G, Justinova Z, Wertheim CE, Yasar S, Piomelli D, Vadivel SK, Makriyannis A, Goldberg SR. J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800 [Abstract] [Full Text] [Related]
4. Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and pain-depressed behavior in rats. Kwilasz AJ, Abdullah RA, Poklis JL, Lichtman AH, Negus SS. Behav Pharmacol; 2014 Apr; 25(2):119-29. PubMed ID: 24583930 [Abstract] [Full Text] [Related]
5. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Cippitelli A, Cannella N, Braconi S, Duranti A, Tontini A, Bilbao A, Defonseca FR, Piomelli D, Ciccocioppo R. Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329 [Abstract] [Full Text] [Related]
6. Reduced anxiety-like behaviour induced by genetic and pharmacological inhibition of the endocannabinoid-degrading enzyme fatty acid amide hydrolase (FAAH) is mediated by CB1 receptors. Moreira FA, Kaiser N, Monory K, Lutz B. Neuropharmacology; 2008 Jan; 54(1):141-50. PubMed ID: 17709120 [Abstract] [Full Text] [Related]
7. Effects of the FAAH inhibitor, URB597, and anandamide on lithium-induced taste reactivity responses: a measure of nausea in the rat. Cross-Mellor SK, Ossenkopp KP, Piomelli D, Parker LA. Psychopharmacology (Berl); 2007 Feb; 190(2):135-43. PubMed ID: 17111174 [Abstract] [Full Text] [Related]
8. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D. J Pharmacol Exp Ther; 2005 Apr; 313(1):352-8. PubMed ID: 15579492 [Abstract] [Full Text] [Related]
9. Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase. Haller VL, Stevens DL, Welch SP. Eur J Pharmacol; 2008 Dec 14; 600(1-3):50-8. PubMed ID: 18762181 [Abstract] [Full Text] [Related]
10. Fatty acid amide hydrolase inhibition heightens anandamide signaling without producing reinforcing effects in primates. Justinova Z, Mangieri RA, Bortolato M, Chefer SI, Mukhin AG, Clapper JR, King AR, Redhi GH, Yasar S, Piomelli D, Goldberg SR. Biol Psychiatry; 2008 Dec 01; 64(11):930-7. PubMed ID: 18814866 [Abstract] [Full Text] [Related]
11. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. Danandeh A, Vozella V, Lim J, Oveisi F, Ramirez GL, Mears D, Wynn G, Piomelli D. Psychopharmacology (Berl); 2018 Nov 01; 235(11):3211-3221. PubMed ID: 30251159 [Abstract] [Full Text] [Related]
12. Dysregulation of the endogenous cannabinoid system in adult rats prenatally treated with the cannabinoid agonist WIN 55,212-2. Castelli MP, Paola Piras A, D'Agostino A, Pibiri F, Perra S, Gessa GL, Maccarrone M, Pistis M. Eur J Pharmacol; 2007 Nov 14; 573(1-3):11-9. PubMed ID: 17644084 [Abstract] [Full Text] [Related]
13. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats. Viana TG, Hott SC, Resstel LB, Aguiar DC, Moreira FA. Psychopharmacology (Berl); 2015 May 14; 232(9):1545-53. PubMed ID: 25388290 [Abstract] [Full Text] [Related]
14. Role of the endocannabinoid system in the dorsal hippocampus in the cardiovascular changes and delayed anxiety-like effect induced by acute restraint stress in rats. Hartmann A, Fassini A, Scopinho A, Correa FM, Guimarães FS, Lisboa SF, Resstel LB. J Psychopharmacol; 2019 May 14; 33(5):606-614. PubMed ID: 30789299 [Abstract] [Full Text] [Related]
15. The Estrous Cycle Influences the Effects of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase Inhibition in the Anxiety-Like Behavior in Rats. Salemme BW, Raymundi AM, Sohn JMB, Stern CA. Cannabis Cannabinoid Res; 2024 Aug 14; 9(4):e1063-e1074. PubMed ID: 37010373 [Abstract] [Full Text] [Related]
16. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats. Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, Goldberg S. Psychopharmacology (Berl); 2009 Jul 14; 204(4):607-16. PubMed ID: 19259645 [Abstract] [Full Text] [Related]
18. Evaluation of fatty acid amide hydrolase inhibition in murine models of emotionality. Naidu PS, Varvel SA, Ahn K, Cravatt BF, Martin BR, Lichtman AH. Psychopharmacology (Berl); 2007 May 14; 192(1):61-70. PubMed ID: 17279376 [Abstract] [Full Text] [Related]
19. Increased Contextual Fear Conditioning in iNOS Knockout Mice: Additional Evidence for the Involvement of Nitric Oxide in Stress-Related Disorders and Contribution of the Endocannabinoid System. Lisboa SF, Gomes FV, Silva AL, Uliana DL, Camargo LH, Guimarães FS, Cunha FQ, Joca SR, Resstel LB. Int J Neuropsychopharmacol; 2015 Jan 24; 18(8):. PubMed ID: 25618404 [Abstract] [Full Text] [Related]
20. Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Ho WS, Randall MD. Br J Pharmacol; 2007 Mar 24; 150(5):641-51. PubMed ID: 17245358 [Abstract] [Full Text] [Related] Page: [Next] [New Search]